Loring Wolcott & Coolidge Fiduciary Advisors’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Loring Wolcott & Coolidge Fiduciary Advisors’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-1,000	Closed	-$19K	–	912
2017 Q3	$19K	Hold	1,000	–	–	﹤0.01%	515
2017 Q2	$17K	Sell	1,000 -1,000	-50%	-$15.2K	﹤0.01%	510
2017 Q1	$27K	Hold	2,000	–	–	﹤0.01%	472
2016 Q4	$30K	Hold	2,000	–	–	﹤0.01%	443
2016 Q3	$23K	Hold	2,000	–	–	﹤0.01%	472
2016 Q2	$22K	Hold	2,000	–	–	﹤0.01%	478
2016 Q1	$18K	Hold	2,000	–	–	﹤0.01%	488
2015 Q4	$30K	Buy	+2,000	New	+$33.5K	﹤0.01%	481

Other funds holding MNTA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Loring Wolcott & Coolidge Fiduciary Advisors's MNTA Position: Q4 2017 in Review

Loring Wolcott & Coolidge Fiduciary Advisors sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2017, closing a stake of 1,000 shares — an estimated $19K sold.

Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in MNTA in Q4 2015 and held it in 8 quarters. The position peaked at $30K in Q4 2016. 166 funds tracked by Wall St. Rank hold MNTA as of Q4 2017.

Loring Wolcott & Coolidge Fiduciary Advisors reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2017 after selling out during the quarter.
Loring Wolcott & Coolidge Fiduciary Advisors sold 1,000 Momenta Pharmaceuticals, Inc. shares in Q4 2017, an estimated $19K.
Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in Momenta Pharmaceuticals, Inc. in Q4 2015 and held it in 8 quarters.
Loring Wolcott & Coolidge Fiduciary Advisors's Momenta Pharmaceuticals, Inc. position peaked at $30K in Q4 2016.
166 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2017.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q4 2017, filed 8 Feb 2018.